No. | Title | Date | View |
---|---|---|---|
24 | 2021-02-15 | 238 | |
23 | 2021-02-09 | 182 | |
22 |
OliX Pharmaceuticals Announces Completion of $37.2 Million Capital Raise
|
2020-12-04 | 429 |
21 | 2020-11-13 | 418 | |
20 |
OliX Pharmaceuticals Announces Expansion of Collaboration with Laboratoires Théa
|
2020-10-21 | 518 |
19 |
OliX Moves Into Spotlight Amid Strong RNAi Interest, New Platform
|
2020-09-08 | 614 |
18 |
OliX Pharmaceuticals Signs Agreement with LGC Biosearch Technologies
|
2020-06-12 | 786 |
17 | 2020-04-17 | 1063 | |
16 | 2020-03-31 | 999 | |
15 | 2020-03-21 | 969 | |
14 | 2020-03-13 | 763 | |
13 |
|
2019-05-23 | 2129 |
12 | 2019-05-10 | 3117 | |
11 | 2019-04-22 | 3650 | |
10 |
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD
|
2019-03-18 | 2690 |
9 |
OliX Announces Clinical Candidate Nomination for the Treatment of Geographic Atrophy.
|
2019-01-18 | 2518 |
8 |
OliX’s #RNAi therapy gets approval for phase 2 trials
|
2018-11-14 | 2470 |
7 |
OliX, a RNAi therapeutics developer, gets approval for KOSDAQ listing
|
2018-07-23 | 2429 |
6 |
CTA approval for Phase 1 in UK
|
2018-05-30 | 2678 |
5 | 2018-05-30 | 3044 |
- Home
- PR